Unexpected heterogeneity of multifunctional T cells in response to superantigen stimulation in humans

Clinical Immunology

Volumn 146, Issue 2, 2013, Pages 140-152

  McArthur, Monica A ^a,b   Sztein, Marcelo B ^a,b  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

IL 17A; Multifunctional T cells; Staphylococcal enterotoxin B; Superantigen

Indexed keywords

CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 17; INTERLEUKIN 22; ORPHAN NUCLEAR RECEPTOR; RETINOIC ACID RECEPTOR; SUPERANTIGEN; TRANSCRIPTION FACTOR T BET;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL HETEROGENEITY; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MITOGENESIS; NORMAL HUMAN; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; TOXIC SHOCK SYNDROME;

EID: 84872380893     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.12.003     Document Type: Article

References (40)

1. Lappin E., Ferguson A.J. Gram-positive toxic shock syndromes. Lancet Infect. Dis. 2009, 9:281-290.
2. Li H., Llera A., Malchiodi E.L., Mariuzza R.A. The structural basis of T cell activation by superantigens. Annu. Rev. Immunol. 1999, 17:435-466.
3. Arad G., Levy R., Nasie I., Hillman D., Rotfogel Z., Barash U., Supper E., Shpilka T., Minis A., Kaempfer R. Binding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock. PLoS Biol. 2011, 9:e1001149.
4. Schlievert P.M. Role of superantigens in human disease. J. Infect. Dis. 1993, 167:997-1002.
5. Neumann B., Engelhardt B., Wagner H., Holzmann B. Induction of acute inflammatory lung injury by staphylococcal enterotoxin B. J. Immunol. 1997, 158:1862-1871.
6. Proft T., Fraser J.D. Bacterial superantigens. Clin. Exp. Immunol. 2003, 133:299-306.
7. McCormick J.K., Yarwood J.M., Schlievert P.M. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 2001, 55:77-104.
8. Crass B.A., Bergdoll M.S. Involvement of staphylococcal enterotoxins in nonmenstrual toxic shock syndrome. J. Clin. Microbiol. 1986, 23:1138-1139.
9. Lee V.T., Chang A.H., Chow A.W. Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates. J. Infect. Dis. 1992, 166:911-915.
10. Khan A.A., Priya S., Saha B. IL-2 regulates SEB induced toxic shock syndrome in BALB/c mice. PLoS One 2009, 4:e8473.
11. Kolls J.K., Linden A. Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476.
12. Stark M.A., Huo Y., Burcin T.L., Morris M.A., Olson T.S., Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005, 22:285-294.
13. Tilahun A.Y., Holz M., Wu T.T., David C.S., Rajagopalan G. Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndrome. PLoS One 2011, 6:e16764.
14. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
15. Khader S.A., Gopal R. IL-17 in protective immunity to intracellular pathogens. Virulence 2010, 1:423-427.
16. Nigam P., Kwa S., Velu V., Amara R.R. Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection. J. Immunol. 2011, 186:745-753.
17. Kondo T., Takata H., Matsuki F., Takiguchi M. Cutting edge: phenotypic characterization and differentiation of human CD8+ T cells producing IL-17. J. Immunol. 2009, 182:1794-1798.
18. Ito T., Carson W.F.t., Cavassani K.A., Connett J.M., Kunkel S.L. CCR6 as a mediator of immunity in the lung and gut. Exp. Cell Res. 2011, 317:613-619.
19. Sztein M.B., Wasserman S.S., Tacket C.O., Edelman R., Hone D., Lindberg A.A., Levine M.M. Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J. Infect. Dis. 1994, 170:1508-1517.
20. Sztein M.B., Tanner M.K., Polotsky Y., Orenstein J.M., Levine M.M. Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. J. Immunol. 1995, 155:3987-3993.
21. Salerno-Goncalves R., Wahid R., Sztein M.B. Ex Vivo kinetics of early and long-term multifunctional human leukocyte antigen E-specific CD8+ cells in volunteers immunized with the Ty21a typhoid vaccine. Clin. Vaccine Immunol. 2010, 17:1305-1314.
22. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., Koup R.A. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 2003, 281:65-78.
23. Roederer M., Nozzi J.L., Nason M.C. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 2011, 79:167-174.
24. Qian Y., Wei C., Eun-Hyung Lee F., Campbell J., Halliley J., Lee J.A., Cai J., Kong Y.M., Sadat E., Thomson E., Dunn P., Seegmiller A.C., Karandikar N.J., Tipton C.M., Mosmann T., Sanz I., Scheuermann R.H. Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data. Cytometry B Clin. Cytom. 2010, 78(Suppl. 1):S69-S82.
25. Billerbeck E., Kang Y.H., Walker L., Lockstone H., Grafmueller S., Fleming V., Flint J., Willberg C.B., Bengsch B., Seigel B., Ramamurthy N., Zitzmann N., Barnes E.J., Thevanayagam J., Bhagwanani A., Leslie A., Oo Y.H., Kollnberger S., Bowness P., Drognitz O., Adams D.H., Blum H.E., Thimme R., Klenerman P. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3006-3011.
26. McArthur M.A., Sztein M.B. Heterogeneity of multifunctional IL-17A producing S. Typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization. PLoS One 2012, 7:e38408.
27. Darrah P.A., Patel D.T., De Luca P.M., Lindsay R.W., Davey D.F., Flynn B.J., Hoff S.T., Andersen P., Reed S.G., Morris S.L., Roederer M., Seder R.A. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 2007, 13:843-850.
28. Kannanganat S., Ibegbu C., Chennareddi L., Robinson H.L., Amara R.R. Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J. Virol. 2007, 81:8468-8476.
29. Kannanganat S., Kapogiannis B.G., Ibegbu C., Chennareddi L., Goepfert P., Robinson H.L., Lennox J., Amara R.R. Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines. J. Virol. 2007, 81:12071-12076.
30. Infante-Duarte C., Horton H.F., Byrne M.C., Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 2000, 165:6107-6115.
31. Annunziato F., Cosmi L., Santarlasci V., Maggi L., Liotta F., Mazzinghi B., Parente E., Fili L., Ferri S., Frosali F., Giudici F., Romagnani P., Parronchi P., Tonelli F., Maggi E., Romagnani S. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007, 204:1849-1861.
32. Seder R.A., Darrah P.A., Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 2008, 8:247-258.
33. Krakauer T. Induction of CC chemokines in human peripheral blood mononuclear cells by staphylococcal exotoxins and its prevention by pentoxifylline. J. Leukoc. Biol. 1999, 66:158-164.
34. Jadidi-Niaragh F., Mirshafiey A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand. J. Immunol. 2011, 74:1-13.
35. Zenewicz L.A., Flavell R.A. Recent advances in IL-22 biology. Int. Immunol. 2011, 23:159-163.
36. Le Bourhis L., Guerri L., Dusseaux M., Martin E., Soudais C., Lantz O. Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol. 2011, 32:212-218.
37. Kleinschek M.A., Boniface K., Sadekova S., Grein J., Murphy E.E., Turner S.P., Raskin L., Desai B., Faubion W.A., de Waal Malefyt R., Pierce R.H., McClanahan T., Kastelein R.A. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J. Exp. Med. 2009, 206:525-534.
38. Esplugues E., Huber S., Gagliani N., Hauser A.E., Town T., Wan Y.Y., O'Connor W., Rongvaux A., Van Rooijen N., Haberman A.M., Iwakura Y., Kuchroo V.K., Kolls J.K., Bluestone J.A., Herold K.C., Flavell R.A. Control of TH17 cells occurs in the small intestine. Nature 2011, 475:514-518.
39. Dong C. Genetic controls of Th17 cell differentiation and plasticity. Exp. Mol. Med. 2011, 43:1-6.
40. Fujii T., Takada-Takatori Y., Kawashima K. Roles played by lymphocyte function-associated antigen-1 in the regulation of lymphocytic cholinergic activity. Life Sci. 2007, 80:2320-2324.